# A6.5-A Independent Review Report

## 1. Review time and scope

Independent review of Phase A6.5-A Discovery and Quarantine (PR #13).

Reviewed implementation artifacts and planning dependencies only. This is not an A6.5-B implementation task.

## 2. Exact Enterprise SHA

```text
7f64c99d0e009e0285c25a55314d608b078e9b46
```

## 3. Exact Implementation SHA (review base)

```text
d2ed18a310d7abbaeb09a7a615773c2e29d74593
```

## 4. Review branch and worktree

```text
Branch: agent/phase-a6-5-a-independent-review
Worktree: D:\project\AIdoctor-a6-5-a-independent-review
```

## 5. PR #13 state at review start

```text
OPEN
DRAFT
NOT_MERGED
Base: agent/enterprise-agent-refactoring-plan @ 7f64c99…
Head: agent/phase-a6-5-a-discovery-quarantine @ d2ed18a…
Changed files: 8
Commits: 2
```

## 6. Review method

- Standard CSV parser for all planning/evidence CSVs.
- Recompute counts from files (do not trust summaries).
- Bidirectional reference checks: Inventory ↔ Discovery ↔ Quarantine ↔ Validation ↔ Risk.
- Path existence via `git ls-files` / tracked-set only.
- `git grep -l` treated as filename reference evidence only, not behavior proof.
- No live/staging access; no patient-content inspection; no clinical body extraction.

Local one-shot analyzer/fix scripts were used and are not committed.

## 7. Safety boundary confirmation

```text
Patient-data content inspected: no
Live/staging stores accessed: no
Clinical content extracted: no
Clinical rules/thresholds/hypotheses/sources approved: 0
Lifecycle: DRAFT
Runtime: NOT_IMPLEMENTED
Production: BLOCKED
A6.5-B: NOT_STARTED
TASK-B04: BLOCKED
A7: NOT_STARTED
External model/API called: no
```

Accurate PHI statement:

```text
PHI_CAPABLE_PATH_ONLY
Tracked real patient records found: 0
No tracked patient records were found in the static repository scan.
Runtime paths remain PHI-capable and uninspected.
```

## 8. Recomputed key statistics

### Before independent-review remediation

```text
Inventory assets: 203
Discovery rows: 203
Quarantine rows: 91
Unique quarantined assets: 85
Validation evidence rows: 304
Risk themes/rows: 8
Backlog tasks: 13
PHI-capable assets: 18
Clinical candidates: 9
Missing eval suites: 3
```

### After independent-review remediation

```text
Inventory assets: 203
Discovery rows: 203
Quarantine rows: 90
Unique quarantined assets: 87
Validation evidence rows: 303
Risk themes/rows: 8
Backlog tasks: 13
PHI-capable assets: 18
Clinical candidates: 9
Missing eval suites: 3

P0/P1/P2/P3: 77/72/52/2
TRACKED_FILE: 187
TRACKED_DIRECTORY_SUMMARY: 8
RUNTIME_PATH_ONLY: 5
MISSING_EXPECTED_ASSET: 3
VALIDATED_FOR_DISCOVERY: 195
RUNTIME_PATH_CONFIRMED: 5
MISSING_EXPECTED_ASSET results: 3
```

Quarantine unique assets increased because RISK-004 path-injection assets (`DOC-021`, `PROMPT-004`) now have explicit quarantine membership in addition to medical-source coverage.

## 9. Discovery completeness

```text
Inventory asset without Discovery: 0
Discovery asset missing from Inventory: 0
Duplicate discovery_id: 0
Duplicate discovery asset_id: 0
Broken reference_paths against tracked files (non-runtime/missing): 0
P0/P1 with path_status: 149/149
P0 with risk_basis: 77/77
```

`git grep -l` filename hits are reference evidence only and are not claimed as runtime call-graph verification.

## 10. PHI path completeness

```text
PHI-capable assets: 18
PHI assets with Discovery: 18
PHI assets quarantined at path level: 18
Confirmed tracked patient records: 0
Content inspected: no
```

No PHI asset is described as confirmed patient data.

## 11. PHI-006 reclassification review

```text
Before: RUNTIME_PATH_ONLY
After: TRACKED_DIRECTORY_SUMMARY
Tracked files under path: 6
```

Evidence: git-tracked files under `frontend/src/components/cdp-visualization/`.

Retained:

```text
risk_level: P0
risk_basis: PHI_CAPABLE_PATH
phi_path_class: PHI_CAPABLE_API_PATH
proposed_disposition: QUARANTINE
quarantine status: QUARANTINED_AT_PATH_LEVEL under RISK-001
```

PHI risk was not downgraded because the directory is version-controlled.

## 12. Clinical candidate review

Expected/registered: 9/9

```text
CLIN-020 CLIN-021 CLIN-022 CLIN-025 CLIN-026
PROMPT-001 PROMPT-003 PROMPT-004 PROMPT-008
```

```text
Status: REGISTERED_PATH_ONLY
Clinical content extracted: no
TASK-B04: BLOCKED
Broken candidate references: 0
```

No clinically validated / approved / ready-for-migration language accepted.

## 13. Quarantine business-key review

Business unique key enforced:

```text
(asset_id, risk_id)
```

```text
Duplicate quarantine_id: 0
Duplicate (asset_id, risk_id) before: 6
Duplicate (asset_id, risk_id) after: 0
```

DATA-DR001..006 LICENSE + DR.KNOWS reasons merged into one RISK-003 row each, with DR.KNOWS-specific unblock evidence.

## 14. Risk theme membership review

```text
Unknown quarantine risk_id: 0
Quarantine asset outside linked risk theme before: 40
Quarantine asset outside linked risk theme after: 0
```

Remediation:

- Expanded `RISK-003.related_asset_ids` for DATA-S*, DATA-DR*, DATA-K*, DR.KNOWS (`DOC-019`, `MODEL-008`), and KG medical-source license aspects.
- Added explicit `RISK-004` quarantine rows for path-injection assets (`DATA-KG004..006`, `DOC-021`, `PROMPT-004`).

Open residual (non-blocking):

- `DATA-KG001..003` remain license-quarantined under RISK-003; inventory `risk_basis=RUNTIME_COUPLING_BLOCKER` documents residual architecture coupling without inventing a new risk theme in this review.

## 15. Validation method review

TASK-A02 methods after fix:

```text
LICENSE_REVIEW: 67
PRIVACY_REVIEW: 18
MANUAL_ARCHITECTURE_REVIEW: 5
```

```text
actual_result: EVIDENCE_RECORDED_FAIL_CLOSED
status: EXECUTED
```

These methods record the review domain used for fail-closed evidence creation. They do **not** mean privacy/legal/architecture approval completed.

## 16. Owner / reviewer / unblock evidence review

```text
owner_role: UNASSIGNED (assigned owner absent)
notes: assigned_owner=UNASSIGNED; required_owner_role=<role>
reviewer_roles: domain-specific
unblock_evidence templates: 4 (PHI / license / DR.KNOWS / path-injection)
```

No invented personal owner names.

## 17. Planning statistics review

```text
Risk themes/rows: 8 (unchanged; theme rows ≠ prior finding counts)
Backlog tasks: 13
Plan text fixed: "12 tasks" -> "13 tasks"
OD-001..OD-006: remain fail-closed / unresolved
OD-007: ACKNOWLEDGED
```

## 18. A6 regression results

```text
Python: 3.13.5
pip check: No broken requirements found
Validator: 11 schemas / 25 assets / 5 eval cases / 0 issues
Pytest: 59 passed
git diff --check: clean (post-commit expectation)
CI: NO_CI_CONFIGURED
```

Local verification is not CI PASS.

## 19. Findings summary

```text
P0: 0
P1: 6 (all fixed)
P2: 3 (2 fixed, 1 open residual documentation)
P3: 1 (fixed via review wording)
```

See `a6-5-a-independent-review-findings.csv`.

## 20. Fixed issues

- Quarantine business duplicates for DATA-DR*.
- RISK-003 / RISK-004 membership alignment.
- Validation ID uniqueness.
- Validation method domain specialization.
- Unblock evidence specialization.
- Plan backlog task count.
- Owner-role semantic clarification in notes.
- PHI-006 evidence confirmation.
- Report quarantine statistics update.

## 21. Unresolved issues

- F-A65A-R09 (P2, open): KG001..003 residual runtime-coupling theme beyond license quarantine; deferred (no new risk invented here).
- OD-001..OD-006 remain unresolved by design.
- TASK-B04 remains BLOCKED.
- RISK-001..RISK-005 remain OPEN.

## 22. Stop conditions

```text
POTENTIAL_REAL_PATIENT_DATA_FOUND: no
UNAUTHORIZED_CONTENT_ACCESS_REQUIRED: no
A6_5_A_BASE_MOVED: no
A6_5_A_TARGET_MOVED: no
WORKTREE_NOT_SAFE: no
A6_5_A_REVIEW_REGRESSION_FAILED: no
```

## 23. Final recommendation

```text
READY_FOR_A6_5_A_REVIEW_FIX_PR
```

Meaning only:

- This independent Review/Fix Draft PR may be human-reviewed.
- PR #13 remains Draft and must not be merged yet.
- After this Review/Fix PR merges into the A6.5-A implementation branch, PR #13 must be re-verified.
- A6.5-B remains NOT_STARTED.
